chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 04Nov2022 at 11:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 54 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), in left arm, on 19Nov2021 at 13:00 as dose 2, single (Batch/Lot number: unknown), in left arm and on 20May2022 at 13:00 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing), notes: High blood pressure. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Feb2023, outcome "unknown" and all described as "COVID-19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.
Counterfeit product administered; A spontaneous report was received from a Consumer concerning a 68 years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) reported regarding a possible vaccine counterfeit.  The patient's medical history was not provided. No relevant concomitant medications were reported.    On 29 Jan 2021, the patient received their first of two planned doses of mRNA-1273  (batch number - 012M20A) via unknown route for COVID-19 infection and reported regarding a possible vaccine counterfeit.  No Treatment information has been provided.   Action taken with mRNA-1273 in response to the events was unknown.   The outcome, counterfeit product administered, was considered resolved.; Reporter's Comments: This report refers to a case of counterfeit product for mRNA-1273, batch number - 012M20A,  with no associated AEs. Causality is not applicable.
debilatating headaches and fatigue, began in june doctor diagnosed as migraine and has been treating.  the headaches have been non stop.  i have about 2 good days out of a week and 4 days that i spend in bed with severe pain.
Pt had a febrile seizure the day after MMR. Has had a febrile sz history, family  h/o of seizures (mom & brother). Pt treated & released from E/R stable.
COVID-19 TEST POSITIVE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, and batch number: 1805022 expiry: UNKNOWN) dose was not reported, administered on 05-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 2021, the subject experienced covid-19 test positive. Laboratory data included: COVID-19 virus test (NR: not provided) Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of covid-19 test positive was not reported. This report was non-serious.; Sender's Comments: V0: Medical Assessment Comment not required as per standard procedure as case assessed as non-serious.
Fatigue at 4:00 pm. Headache later in evening. Next day nausea, dizziness, fatigue, low fever. Arm pain.
Pt received Tdap and PPD approx 10:45 AM on 9-2-2014. Pt reports awaking in night with shaking, chills, c/o weakness, low back pain, feels swollen at neck with no sore throat. Felt nausea with no vomiting.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Physician). The reporter is the patient.  A 36-year-old female patient (pregnant) received BNT162b2 (BNT162B2), on 04Mar2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 35 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Depression" (unspecified if ongoing); "overweight" (unspecified if ongoing). Date of last menstrual period: 11Oct2021. The patient was 20 weeks pregnant at the time of exposure to BNT162b2. The patient was 38 weeks pregnant at the event onset. The patient is expected to deliver a baby(s) on 18Jul2022. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (20Jun2022) Positive, notes: had positive home antigen and pos PCR on 20Jun; (23Jun2022) Negative, notes: Symptoms improved and had negative home.Antigen tests 23Jun and 24Jun; (24Jun2022) Negative, notes: Symptoms improved and had negative home, antigen tests 23Jun and 24Jun; (01Jul2022) Positive, notes: Onset of rebound symptoms on 01Jul and positive home antigen test. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information provided in the narrative, a causal association between the suspect drug and the events cannot be completely excluded.
On 12/28/02 I was given a tetanus shot after being treated for cut finger with stitches administered. 12/30/02 weak, sweaty, hard to breathe. 12/31/02 head very whoosey, right armpit with swollen lump in area. By 1/2/03 right eye very painful and blurred, then both eyes got very blurred and painful, temples swollen, right arm red, swollen and hard. Difficult swallowing at times. As of 5/28/03 I'm still having problems - muscle pain, blurred vision, temple swelling.
Headache, Fever, Diarrhea, Swelling at the injection site, chills, sinus headache with neck pain. Fever up to 102.9 degrees F Narrative:  She has been taking Motrin 400 mg Q6H and Tylenol 1000 mg Q4H for the fever 102.5-102.9 degrees F. The fever/chills and headache developed 15 hours post seconded vaccine; diarhhea after 48 hours.
Subsequent to receiving vax pt was found to be in early part of pregnancy at the time of administration. The most recent information reports the outcome of the event is unknown. The vacinee was a thalassemia carrier and a beta streptoccus carrier, for which she was treated with ampicillin (treatment was complete approximately one week priori to admission to the hospital) The vaccinee had delivered two full term children previously by ceserean action. In April 1999, in May 1999, and on May 04, 2000, the vacinee received her first, secondm and thrid dose of Lymerix, respectively. She became pregnant at the end of May 2000. The date of her last menstrual period was April 27, 2000, and the esimated date of confinement was Feb 01, 2001. On Dec 05, 2000, the vaccinee delivered twins by cesarean section at 31 weeks gestational age due to premature spontaneous onset of labor and prior cesarean section. Twin A was a female weighting 4 lbs 5 ounces at birth. Her Apgar scores were 9 and 9. Twin B was a male weighing 3 lbs 10 ounces at birth. His Apgar scores were 9 and 8. Both babies were deliverd by total breech extraction, even though twin B presented as a vertex presentation. The reporter stated that the neonatal status was normal, the twins were viable, no problems were noted, and the delivery was tolerated well. At the time of the cesarean section, the patient underwent a tubal litigation. The vaccinee's post operative course was additionally complicated by upper respiratory congestion and some difficulty breathing. She was seen by an ENT (ear, nose, and throat) specialist, who made a diagnosis of vocal cord polyps. These were removed by microlaryngoscopy on Dec 07, 2000. The remainder of the patient's post operative coure was uneventful. The mother was discharged from the hospital on Dec 09, 2000 and the infants were sent home at an unknown later date. Discharge diagnosis (mother) 1 pregnacy, 31 weeks, twin gestation: multiperity 2 Anemia 3 Vocal cord polys. As of May 14, 2001 mother and infants were doing well.
PT ONSET OF EVENTS SAME DAY SHE RECVD ENGERIX-B:REDNESS, WARMTH AT SOI, WITH VERY SLIGHT SWELLING.  TREATMENT OF ICE-PACK AND 2 TABLETS OF ADVIL.
Patient broke out in severe Hives. Also, she has swollen fingers and pain in her wrists.
Customer did not notify pharmacist that he had already received two doses of Pfizer Covid vaccine previously. It was also not documented in vaccine database. Moderna single dose # 1 was administered, then customer notified pharmacist that he was wanting a "booster" shot since he had already gotten two doses. He was aware that the booster shots were not authorized at this time. He had not reported any adverse effects from receiving the Moderna vaccine.
little bit of rash/ every place on his body; Thought it may be eczema; Scabies; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 21 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RASH (non-serious), outcome "unknown", described as "little bit of rash/ every place on his body"; ECZEMA (non-serious), outcome "unknown", described as "Thought it may be eczema"; ACARODERMATITIS (non-serious), outcome "unknown", described as "Scabies". The events "little bit of rash/ every place on his body", "thought it may be eczema" and "scabies" were evaluated at the physician office visit. Therapeutic measures were taken as a result of rash, eczema, acarodermatitis.  Additional information: When probed for the concern, reporter stated, "His son (patient) took the Pfizer Vaccine as we all did and probably a week or two week after he took the vaccine he develop a little bit of rash, they thought that was may be eczema they treated it for eczema through the Doctor Program here in and he didn't even touch it, then they treated it for scabies because one of the kid it was presumed had scabies in the Health but that was not clearing up either, the antibiotic Cream that was prescribed (unspecified medication), so last night reporter visited the website and looked at some of the pictures of some of the people that were having allergic reaction to the Pfizer vaccine, so his leg and arm look just like the pictures so reporter's question was, are you guys giving any advice about how to treat these infection.  Follow-up (24Dec2021): This is a spontaneous follow up report received from a same contactable consumer. This consumer (patient's parent) reported for a male patient (reporter's son) that: Update Information: Patient age.  Follow-up (13Jan2022): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
ITCHING AND RASH TO LOWER ARM BETWEEN ELBOW AND WRIST ON LEFT ARM AND SMALL PATCH OF RASH ON RIGHT ARM NEAR WRIST, BOTH LASTING ABOUT 24-48 HOURS
Dizziness, fatigue, hallucinations, temp of 102, headache, body pain, nausea, vomiting
other zoster-related conditions; shingles; Information has been received from a lawyer regarding a case in litigation which referred to a patient (pt) of unknown gender and age. Information regarding concomitant medications, concurrent conditions or medical history was not provided. On or about 07-NOV-2013, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) for its intended purpose: the long-term prevention of shingles (herpes zoster) and for zoster-related conditions (exact dose, dose number, route of administration, anatomical site of vaccination, lot number and expiration date were not provided). Afterwards, on an unknown date (reported as after receiving zoster vaccine live (ZOSTAVAX) vaccine), the pt suffered shingles (herpes zoster) and zoster-related conditions (ill-defined disorder). As a result of those symptoms, the pt was seen and treated by a physician. Further, the pt had suffered and would continue to suffer ongoing injuries including but not limited to: mental and physical pain and suffering; medical care and treatment for those injuries; significant medical and related expenses as a result of those injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of the events was unknown. The causal relationship between the events and zoster vaccine live (ZOSTAVAX) was assessed as related.
10 Y/O MALE PRESENTS WITH MILD ANXIETY PRIOR TO COVID-19 PEDIATRIC DOSE OF PFIZER VACCINE. DOSE ADMINISTERED INTO LEFT ARM. PATIENT GETS UP TO WALK TO OBSERVATION AREA AND PASSES OUT AFTER VACCINATION SUSTAINING A MILD BUMP ON THE HEAD.  911 WAS CALLED AND PATIENT EVALUATED AND ABLE TO LEAVE BY THEIR OWN POWER. (ACCOMPANIED BY MOTHER)
Information has been received from a doctor of osteopathic medicine (D.O.) concerning a female who on an unspecified date was vaccinated with the first dose of GARDASIL (LOT # was not reported). On an unspecified date, after vaccination the patient experienced injection site pain and a hive reaction. The patient also was reported as recovered on an unspecified date. Additional information has been requested.
Itching with the Moderna covid vaccine/ she had itching. had itching on her head, hands, and body; She used to drink some wine and now she cant drink after the Moderna vaccine; This spontaneous case was reported by a patient and describes the occurrence of PRURITUS (Itching with the Moderna covid vaccine/ she had itching. had itching on her head ,hands, and body) and ILL-DEFINED DISORDER (She used to drink some wine and now she cant drink after the Moderna vaccine) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. Patients family all had good eyes. Her mom died at 87 with no sickness.  Family history included Alzheimer's disease (Patient's husband has Alzheimer's) since an unknown date. Concurrent medical conditions included Rheumatoid arthritis (A long time ago patient had a rheumatoid arthritis medicine.) and Thyroid disorder NOS. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder NOS. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching with the Moderna covid vaccine/ she had itching. had itching on her head,hands, and body) and ILL-DEFINED DISORDER (She used to drink some wine and now she cant drink after the Moderna vaccine). At the time of the report, PRURITUS (Itching with the Moderna covid vaccine/ she had itching. had itching on her head,hands, and body) was resolving and ILL-DEFINED DISORDER (She used to drink some wine and now she cant drink after the Moderna vaccine) had not resolved. It was reported that, the patient still had a little itching from vaccine. Just a little bit of itching left. She cannot put color on her hair right now. In Las Vegas reaction was not that bad. It got a little better. It took 9 months to get over it. It was reported that patient had no eye problems with Moderna vaccine. No treatment medications were reported.
This spontaneous report as received from a pharmacist refers to a 72 year old male patient with no Drug Reactions/Allergies. On 27-OCT-2014 the patient was vaccinated with a dose of PNEUMOVAX 23 (lot # K006681, expired date 21-OCT-2015), (dose unspecified), intramuscular. On 27-OCT-2014, the patient began to experience "some pain" in the injection arm "a few hours" after the administration. Pharmacist reported that the pain progressively got worse over the next several days and the patient did not sleep for 4 days because of the pain, therefore the patient went to see his unspecified physician on an unspecified date. Pharmacist reported that the physician prescribed FLECTOR patches and MOTRIN for treatment of the pain but the pain had still persisted. Pharmacist reported that the patient was still experiencing severe pain, but it had gotten "a little better". No Lab Diagnostics Studies Performed. The events outcome was recovering. This is one of several reports received from the same source. Additional information has been requested.
A very light headache; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Mar2021 at 11:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and bronchitis. Concomitant medications included epinephrine (PRIMATENE MIST) inhalation aerosol taken from on an unknown date for an unknown indication. The patient had not known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 24Mar2021 at 00:00, the patient experienced a very light headache that did not go away since 14 days after the first shot. The event resulted in a doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event a very light headache and included treatment with TYLENOL. The clinical outcome of the event a very light headache was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.  Amendment: This follow-up report is being submitted to amend previously reported information: Amended patient's middle name in patient tab and narrative.
I started having fever, headache, cough, runny nose cold like symptoms. I took naproxen for the headache and that did help. After finding out my grandson was positive for COVID-19, I then tested that night and was positive as well. Everything was closed because of Christmas so I called the doctor on Tuesday and was told to treat the symptoms. Then my children kept saying get medication so on the 29 of December I called the doctor and a prescription of PAXLOVID was sent to the pharmacy. The PAXLOVID did help all cold like symptoms went away all but the cough.
Since 2021 of June I have had pain in my left ear and neck and head and ears constantly ringing andconstant headaches, also head every day feels like my scalp is being pulled tight. Daily nausea, dizziness,gets so bad I cannot walk. My mouth has a horrible coating on tongue everyday.  I had a infusion done a few months prior to getting covid vaccines because I got covid. I have been to numerous doctors for everything I have and suffer with everyday, had labs, CT scans, MRI and nothing any doctor has tried has worked and I have had these debilitating issues for 3 years now and have been told not to take anymore covid shots cause everything I have wrong is from covid shots. I have no quality of life.
0935- Vaccine recipient (VR) received 0.3ml dose of Pfizer vaccine that was reconstituted with the incorrect amount of diluent (0.9mL).  VR was asymptomatic during 30 minute observation.  Immediately contacted program and was provided guidance and information.  1052 - Consulted School Nurse, VR was in nurses office with chief complaint of a headache, dizziness, and nausea.  Left deltoid observed at injection site with no localized reaction found.  Per school nurse: Nurse gave VR ibuprofen.  Relayed information provided by program to VR.  School nurse continued to observe.   1058- Contacted and spoke with VR's parent and relayed and emailed information provided from program (continued in next section) Additional information for Item 18: cont'd- which was the CDC Guidance for vaccine administration errors and deviations.  Parent advised to contact primary care provider with any questions or concerns.  12:30 - Followed up with VR - headache and dizziness unchanged, nausea resolved, c/o "going the other way" bathroom.  School nurses continued to observe.  VR laying flat on bed, dim lights, and on phone.
After the vaccine, I have been in an RA flare. Despite starting my new infusion medication (9/7/2021) - Actmera -  which was planned anyway, I have now had to start taking daily Prednisone  -  5 mg daily and I am still not out of my flare. Increased pain; increased stiffness in all joints; increased fatigue. General malaise- I just don't feel good.  I have my next infusion appt on 10/6 and then I follow up in December with him (RA doctor).  I have an appt with my PCP on Monday regarding the pain and the inflammation. Note: I received a flu vaccine and a TDAP on September 2nd -  -TDAP vaccine Lot #57G12 - Boostrix; Flurex Quaduvirant. 3SE27
Injection was administered intramuscularly instead of subcutaneously. Patient did not develop any reaction, but we just wanted to report what happened.
This spontaneous report as received from a pharmacist refers to a 59 years old patient with allergy to cephalosporins, quinolones and penicillin DARVOCET. The patient was vaccinated subcutaneously with a dose of 0.65 ml improperly stored ZOSTAVAX (lot number 671786/0254AE, expire date 08-MAR-2013) on 07-JUL-2012. No other co-suspects were reported. No concomitant medications were reported. The vaccine had been exposed to a total of 17 hours at 60F. No adverse effect has been observed or reported. It was unspecified if the patient had sought medical attention. Additional information has been requested.
Headache, severe pain between the breast and the axilla, severe pain in the arm at the elbow joint, difficulty stretching the arm.
2/22/21 Had Nuc scan to eval for blood clots/ there was no evidence 5/12/21 ct scan finds PE post vaccine. in with cough and SOB
Had muscle pain, fatigue, shivering first day. Fever next day of 103.4, fatigue, no appetite. Third day nausea, diarrhea, low grade fever persisted. Called doctor about unusual symptom on second day: very swollen lymph node in neck (one side). Used Tylenol and warm compress to treat. Swelling persisted until day four, but much better.